Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-17
2006-10-17
Jones, Dwayne (Department: 1614)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S416000, C548S417000, C548S420000, C548S427000, C514S410000
Reexamination Certificate
active
07122679
ABSTRACT:
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
REFERENCES:
patent: 4912107 (1990-03-01), Kleinschroth et al.
patent: 5166204 (1992-11-01), Nagai et al.
patent: 5177075 (1993-01-01), Suto et al.
patent: 5587384 (1996-12-01), Zhang et al.
patent: 5728709 (1998-03-01), Ikuina et al.
patent: 6063803 (2000-05-01), Carmosin et al.
patent: 06955755 (1996-02-01), None
patent: 0 768 311 (1997-04-01), None
patent: 768311 (1997-04-01), None
patent: 04230385 (1992-08-01), None
patent: WO 92/14453 (1992-09-01), None
patent: WO 95/24379 (1995-09-01), None
patent: WO 96/11933 (1996-04-01), None
patent: WO 96/28447 (1996-09-01), None
patent: WO 98/09967 (1998-03-01), None
patent: WO 99/08680 (1999-02-01), None
patent: WO 99/11622 (1999-03-01), None
patent: WO 99/11623 (1999-03-01), None
patent: WO 99/11624 (1999-03-01), None
patent: WO 99/11628 (1999-03-01), None
patent: WO 99/11644 (1999-03-01), None
patent: WO 99/11645 (1999-03-01), None
patent: WO 99/11649 (1999-03-01), None
patent: WO 99/41276 (1999-08-01), None
patent: WO 99/47522 (1999-09-01), None
patent: WO 99/59973 (1999-11-01), None
patent: WO 99/59975 (1999-11-01), None
patent: WO 99/65911 (1999-12-01), None
Piers, E. et al.,J. Org. Chem., 2000, 65, 530-535.
Roberge, M. et al.,Cancer Research, 1998, 58, 5701-5706.
Griffin, R.J. et al.,Biochimie, 1995, 77, 408-422.
Moody, C.J. et al.,J. Org. Chem., 1992, 57, 2105-2114.
Noland, W.E. et al.,J. Org. Chem., 1983, 48, 2488-2491.
Jones, R.A. et al.,J. Org. Chem., 1980, 45, 4515-4519.
Fearon, E.R., “Genetic Lesions in Human Cancer” Molecular Oncology, 1996, 143-177.
Szabó, C. et al.,J. Clin. Invest., 1997, 100(3), 723-735.
Heller, B. et al.,The Journal of Biological Chemistry, 1995, 270(19), 11176-11180.
Banasik, M.; Ueda, K.,Molecular and Cellular Biochemistry, 1994, 138, 185-197.
Cosi, C.; Marien, M.,Brain Research, 1998, 809, 58-67.
Takahashi, K. et al.,Brain Research, 1999, 829, 46-54.
Dickens, M. et al.;Science, 1997, 277, 693-696.
Gupta, S. et al.,The EMBO Journal, 1996, 15(11), 2760-2770.
Ruf, A. et al.,Proc. Natl. Acad. Sci., 1996, 93, 7481-7485.
Berlinck, R.G.S. et al.,J. Org. Chem., 1998, 63, 9850-9856.
Hartkamp, J. et al.,Cancer Research, 1999, 59, 2195-2202.
Braunwalder, A.F. et al.,Analytical Biochemistry, 1996, 238, 159-164.
Wang, Z. et al.,Genes&Development, 1995, 9, 509-520.
Scott, G.S. et al.,Ann. Neurol, 1999, 45, 120-124.
Thiemermann, C. et al.,Proc. Natl. Acad. Sci.1997, 94, 679-683.
Pieper, A.A. et al.,Proc. Natl. Acad. Sci., 1999, 96, 3059-3064.
Burkart, V. et al.,Nature Medicine, 1999, 5(3), 314-319.
Yang, D.D. et al.,Nature, 1997, 389, 865-870.
Nishina, H. et al.,Nature, 1997, 385, 350-353.
Laroy, W. et al.,Analytical Biochemistry, 1997, 249, 108-111.
Gilad, E. et al.,J. Mol. Cell. Cardiol., 1997, 29, 2585-2597.
Abrash, H.I.; Niemann, C.,Biochemistry, 1965, 4(1), 99-104.
Mozingo, R.,Org. Synth., 1955, 3, 181-184.
Uchida, K. et al.,Biochem. Biophys. Res. Comm., 1987, 148(2), 617-622.
Ushiro, H. et al.,J. Biol. Chem., 1987, 262(5), 2352-2357.
Brown, D.M. et al.,Int. J. Radiat. Oncol. Biol. Phys., 1984, 10, 1665-1668.
Brown, J.M. et al.,Int. J. Radiat. Biol., 1991, 59(3), 739-748.
Horsman, Michael R. et al.,Int. J. Radiation Oncology Biol. Phys., 1986, 12, 1307-1310.
Hua, Jianyi; Pero, Ronald W.,Acta Oncologica, 1997, 36(8), 811-816.
Kato, T. et al.,Anticancer Res.1988, 8, 239-243.
Masiello, P. et al.,Diabetologia, 1985, 28, 683-686.
Tsujiuchi, T. et al.,Jpn. J. Cancer Res., 1992, 83, 985-988.
Tsujiuchi, T. et al.,Jpn. J. Cancer Res., 1991, 82, 793-799.
Yamamoto, H. et al.,Biochemical and Biophysical Research Communications, 1980, 95(1), 474-481.
Zingarelli, B. et al.,Gastroenterology, 1999, 335-345.
D'Amours, D. et al.,Anal. Biochem., 1997, 249, 106-108.
Gopalakrishna, R. et al.,Anal. Biochem., 1992, 206, 24-35.
Burtscher, H.J. et al.,Anal. Biochem., 1986, 152, 285-290.
Ikejima, M. et al.,Biochem. Biophys. Res. Comm., 1989, 163, 739-745.
Kuehne, M. E.,J. Amer. Chem. Soc., 1959, 81, 5400-5404.
Yang, Z. et al.,Shock, 2000, 13(1), 60-66.
Pitt, A. D.; Lee, C., J.Biomol. Screening, 1996, 1(1), 47-51.
Hodge, P. et al.,J. Chem. Soc., Perkin Trans. I, 1984, 2451-2455.
Sims, J. L. et al.,Biochemistry, 1983, 22, 5188-5194.
Whalen, M. J. et al.,J. Cereb. Blood Flow Metab., 1999, 19, 835-842.
Takahashi, K. et al.,J. Cereb. Blood Flow Metab., 1997, 17, 1137-1142.
Endres, M. et al.,J. Cereb Blood Flow Metab., 1997, 17, 1143-1151.
Alvarez-Gonzalez, R. et al.,Molecular and Cellular Biochemistry, 1994, 138, 33-37.
Ohno, M. et al.,Heterocycles, 1991, 32(6), 1199-1202.
Tashiro, M. et al.,Heterocycles, 1974, 2(5), 575-584.
Suto, M. J. et al.,Anti-Cancer Drug Design, 1991, 7, 107-117.
Yamamoto, H. et al.,Nature, 1981, 294, 284-286.
Banasik, M. et al.,J. Biol. Chem., 1992, 267,(3), 1569-1575.
Mendoza-Alvarez, H.; Alvarez-Gonzalez, R.,J. Biol. Chem., 1993, 268(30), 22575-22580.
Abrash, H. I.; Niemann, C.,Biochemistry, 1965, 4(1), 99-104.
Nakagawa, K. et al.,Carcinogenesis, 1988, 9(7), 1167-1171.
Cherney, B. W. et al.,Proc. Natl. Acad. Sci. USA, 1987, 84, 8370-8374.
Kurosaki, T. et al.,J. Biol. Chem., 1987, 262(33), 15990-15997.
Eitel, M.; Pindur, U.,Synthesis, 1989, 364-367.
Pindur, U.; Eitel, M.,Helv. Chim. Acta, 1988, 71, 1060-1064.
Tschaen, D. M., et al.,Synth. Commun., 1994, 24(6), 887-890.
Giner, H. et al.,Gene, 1992, 114, 279-283.
Kozikowski, A.,J. Org. Chem., 1984, 49, 3239-3240.
Cuzzocrea, S.,Eur. J. Pharmacology, 1998, 342, 67-76.
Korpelainen, E. I.; Alitalo, K.,Curr. Opin. Cell Biol., 1998, 10, 159-164.
Ip, Y. T.; Davis, R. J.,Curr. Opin. Cell. Biol., 1998, 10, 205-219.
Ortéga, N. et al.,Frontiers in Bioscience, 1999, 4, d141-152.
Katoh, M. et al.,Oncogene, 1995, 10, 1447-1451.
Zingarelli, B. et al.,Cardiovascular Research, 1997, 36, 205-215.
Panzeter, P. L. et al.,J. Chromatography A, 1994, 678, 35-40.
Mahboobi, S. et al.,Tetrahedron, 1996, 52(18), 6373-6382.
McCort, G. et al.,Tetrahedron Lett., 1999, 40, 6211-6215.
Purnell, M. R.; Whish, W.J.D.,Biochem. J., 1980, 185, 775-777.
Tokime, T. et al.,J. Cereb. Blood Flow Metab., 1998, 18, 991-997.
Kruto{hacek over (s)}iková, A. et al.,Coll. Czech. Chem. Commun., 1988, 53, 1770-1778.
Muchowski, J. M.; Scheller, M.E.,Tetrahedron Lett., 1987, 28(30), 3453-3456.
Masiello, P. et al.,Res. Commun. Chem. Pathol. Pharmacol., 1990, 69(1), 17-32.
Harris, W. et al.,Tetrahedron Lett., 1993, 34(51), 8361-8364.
Eitel, M.; Pindur, U.,J. Org. Chem., 1990, 55, 5368-5374.
Rewcastle, G. W. et al.,J. Med. Chem., 1996, 39, 918-928.
Leonard, N. J. et al.,J. Amer. Chem. Soc., 1976, 98, 3987-3994.
de Murcia, G.; de Murcia, J. M.,Trends Biochem. Sci., 1994, 19, 172-176.
Zhang, J. et al.,Science, 1994, 263, 687-689.
Eliasson, M.J.L. et al.,Nature Med., 1997, 3(10), 1089-1095.
Mandir, A.S. et al.,Proc. Natl. Acad. Sci., 1999, 96, 5774-5779.
Ator Mark A.
Bihovsky Ron
Chatterjee Sankar
Dunn Derek
Hudkins Robert L.
Cephalon Inc.
Cephalon, Inc.
Jones Dwayne
LandOfFree
Multicyclic compounds and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multicyclic compounds and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multicyclic compounds and the use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681107